| dc.contributor.author | Patrikidou, A | |
| dc.contributor.author | Uccello, M | |
| dc.contributor.author | Tree, A | |
| dc.contributor.author | Parker, C | |
| dc.contributor.author | Attard, G | |
| dc.contributor.author | Eeles, R | |
| dc.contributor.author | Khoo, V | |
| dc.contributor.author | van As, N | |
| dc.contributor.author | Huddart, R | |
| dc.contributor.author | Dearnaley, D | |
| dc.contributor.author | Reid, A | |
| dc.date.accessioned | 2017-07-19T10:43:58Z | |
| dc.date.issued | 2017-10-01 | |
| dc.identifier.citation | Clinical oncology (Royal College of Radiologists (Great Britain)), 2017, 29 (10), pp. e174 - e175 | |
| dc.identifier.issn | 0936-6555 | |
| dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/706 | |
| dc.identifier.eissn | 1433-2981 | |
| dc.identifier.doi | 10.1016/j.clon.2017.06.006 | |
| dc.format | Print-Electronic | |
| dc.format.extent | e174 - e175 | |
| dc.language | eng | |
| dc.language.iso | eng | |
| dc.publisher | ELSEVIER SCIENCE LONDON | |
| dc.rights.uri | https://www.rioxx.net/licenses/all-rights-reserved | |
| dc.title | Upfront Docetaxel in the Post-STAMPEDE World: Lessons from an Early Evaluation of Non-trial Usage in Hormone-Sensitive Prostate Cancer. | |
| dc.type | Journal Article | |
| dcterms.dateAccepted | 2017-06-06 | |
| rioxxterms.versionofrecord | 10.1016/j.clon.2017.06.006 | |
| rioxxterms.licenseref.uri | https://www.rioxx.net/licenses/all-rights-reserved | |
| rioxxterms.licenseref.startdate | 2017-10 | |
| rioxxterms.type | Journal Article/Review | |
| dc.relation.isPartOf | Clinical oncology (Royal College of Radiologists (Great Britain)) | |
| pubs.issue | 10 | |
| pubs.notes | Not known | |
| pubs.organisational-group | /ICR | |
| pubs.organisational-group | /ICR/Primary Group | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Closed research teams | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Closed research teams/Clinical Academic Radiotherapy (Dearnaley) | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Genetics and Epidemiology | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Oncogenetics | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Treatment Resistance | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Clinical Academic Radiotherapy (Huddart) | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Oncogenetics | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Stereotactic and Precision Body Radiotherapy | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Stereotactic and Precision Body Radiotherapy/Stereotactic and Precision Body Radiotherapy (hon.) | |
| pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
| pubs.organisational-group | /ICR | |
| pubs.organisational-group | /ICR/Primary Group | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Closed research teams | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Closed research teams/Clinical Academic Radiotherapy (Dearnaley) | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Genetics and Epidemiology | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Oncogenetics | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Treatment Resistance | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Clinical Academic Radiotherapy (Huddart) | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Oncogenetics | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Stereotactic and Precision Body Radiotherapy | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Stereotactic and Precision Body Radiotherapy/Stereotactic and Precision Body Radiotherapy (hon.) | |
| pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
| pubs.publication-status | Published | |
| pubs.volume | 29 | |
| pubs.embargo.terms | Not known | |
| icr.researchteam | Clinical Academic Radiotherapy (Dearnaley) | |
| icr.researchteam | Treatment Resistance | |
| icr.researchteam | Clinical Academic Radiotherapy (Huddart) | |
| icr.researchteam | Oncogenetics | |
| icr.researchteam | Stereotactic and Precision Body Radiotherapy | |
| dc.contributor.icrauthor | Eeles, Rosalind | |
| dc.contributor.icrauthor | Huddart, Robert | |
| dc.contributor.icrauthor | Dearnaley, David | |
